Drug Delivery Matrix

About Encoll

Encoll is a private, commercial-stage medical device and biomaterials company with a proprietary platform for producing ultra-pure, phosphorylated Type-I collagen. Its flagship product, Helicoll®, is an acellular dermal substitute approved for wound management and has secured an Innovative Technology contract with Vizient, Inc. The company leverages its patented Two-step enzyme Treatment Process (TTP) to serve multiple sectors, including surgical applications, biotechnology research, and skincare, positioning itself as a specialized supplier of bioactive collagen.

Therapeutic Areas